7/14/2022China's Budding Drug Innovation Shows Signs of Life Despite Biotech Wi...

7/13/2022Chinese Drugmakers Set Sights on Emerging Markets (PharmaDJ)

7/13/2022Chinese Biopharma Out-licensing Deals in H1/2022 (Pharmcube)

7/12/2022AstraZeneca, Pfizer, Novartis and More Lose Out in China's Latest Roun...

7/12/2022Youtube Video: Layoff Triggered in China's Pharma as Beijing Continues...

7/12/2022JPO Publicizes 7th VBP Tender Outcome, Which Slashes Average Prices by...

7/11/2022NMPA Announces OTC Switch of Potassium Glucosamine Sulfate Tablets

7/11/2022Tasly Pharma and Mauna Kea Tech Announce JV and Licensing Pact

7/8/2022Chinese Government Issues New Document to Secure Urban/Rural Resident ...

7/8/2022Sinopharm Explores $1 Billion Deal for BBI Life Sciences

7/7/2022Pharmaron Acquires Commercial API Manufacturing Facility in the U.S.

7/6/2022Illumina and Sequoia Capital Launch Genomics Startup Incubator in Chin...

7/5/2022Biotech Winter in China Set to Adjust Valuation and Prompt Consolidati...

7/1/2022PharmaDJ: MSD and Turning Point Turn to China for Big Deals in May

7/1/2022PhIIC: Representative Hospital Drug Sales Nears CNY 60B in Q1/2022

7/1/2022Recent Executive Moves

7/1/2022Solasia to Slash 65% of Workforce in China as It Transfers Core Distri...

6/29/2022WuXi STA Opens Another High-Potency API Plant In Changzhou

6/29/2022NMPA Issues the Implementation Plans for Manufacture by Hong Kong and ...

6/29/2022Nature: Unleashing the Power of Big Data to Guide Precision Medicine i...

6/28/2022NMPA Issues Notice to Further Strengthen Services to Foreign-Invested ...

6/28/2022BioLineRx and GenFleet Agree to Further Develop Motixafortide in PDAC...

6/27/2022Snapshot of Patient Expenditures of Level II and Above Public Hospital...

6/27/2022Amgen Strikes Outliciensing Deal with Fosun for Otezla and Parsabiv in...

6/27/2022Antengene Enters Clinical Partnership with BeiGene to Evaluate Selinex...

6/24/2022At ASCO 2022, Chinese Biotech Firms Deliver Rosy Data On PD-(L)1, Cell...

6/23/2022Sino Biopharmaceutical to Acquire F-Star Therapeutics for $161M

6/23/2022NMPA Announces Package Insert Revision of Glucosamine Formulations

6/23/2022Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...

6/22/2022China's Mental-health Crisis Is Getting Worse (Economist)

Page:64/356 Total number of articles:10671: [First][<<] [62] [63] [64] [65] [66] [>>] [End]